A Guide to the Investigational Peptide

alluvi retatrutide 10mgInterest in Alluvi Retatrutide 10mg has grown alongside increasing public attention toward retatrutide, an investigational medicine being studied for obesity, type 2 diabetes, and other metabolic conditions. For anyone researching this product, it is important to understand the difference between an online research-grade peptide and an approved prescription medicine.What Is Retatrutide?Retatrutide is an investigational once-weekly medicine developed by Eli Lilly. It is a triple receptor agonist, meaning it activates the GIP, GLP-1, and glucagon receptors. Researchers are studying this mechanism for its potential effects on body weight, glucose regulation, and broader metabolic health.